30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

ImmunoCellular Therapeutics Ltd (IMUC)

Track

Stock chart
Ticker: IMUC Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Gengos Andrew
President and CEO
1 purchase — total 4,350 USD
Buy 30 Nov 2015
Value US$3,289,321.65 | Price 75.86 | Shares 12,011
Buy 18 Feb 2015
Value US$3,604,302.95 | Price 491.03 | Shares 60,499
Buy 18 Feb 2015
Value US$24,799.80 | Price 0.60 | Shares 41,333
Buy 18 Feb 2015
Value US$10,000.20 | Price 0.60 | Shares 16,667
Buy 21 Aug 2014
Value US$10,010.00 | Price 0.91 | Shares 11,000
Buy 14 Aug 2014
Value US$8,994.00 | Price 0.90 | Shares 10,000
Buy 20 Dec 2013
Value US$13,962.00 | Price 0.78 | Shares 17,900
Buy 20 Dec 2013
Value US$77.99 | Price 0.78 | Shares 100
Buy 18 Dec 2013
Value US$19,361.70 | Price 0.72 | Shares 27,000
Planned sale 26 Nov 2013
Value US$32,030.24 | Price 3.86 | Shares 8,301
Planned sale 26 Nov 2013
Value US$76,010.56 | Price 3.86 | Shares 19,699
Planned sale 25 Nov 2013
Value US$106,095.92 | Price 3.50 | Shares 30,301
Planned sale 25 Nov 2013
Value US$75,447.50 | Price 3.02 | Shares 25,000
Sale 21 Oct 2013
Value US$105,079.91 | Price 2.92 | Shares 36,006
Planned sale 18 Oct 2013
Value US$92,875.30 | Price 2.85 | Shares 32,613
Planned sale 18 Oct 2013
Value US$673,226.16 | Price 2.91 | Shares 231,381
Sale 29 Aug 2013
Value US$2,700.00 | Price 3.00 | Shares 900
Sale 28 Aug 2013
Value US$14,400.00 | Price 2.88 | Shares 5,000
Sale 28 Aug 2013
Value US$9,413.55 | Price 2.85 | Shares 3,303
Sale 28 Aug 2013
Value US$14,200.00 | Price 2.84 | Shares 5,000
Sale 1 Jun 2012
Value US$2,166.00 | Price 3.61 | Shares 600
Sale 1 Jun 2012
Value US$17,640.00 | Price 3.60 | Shares 4,900
Sale 1 Jun 2012
Value US$5,385.00 | Price 3.59 | Shares 1,500
Sale 31 May 2012
Value US$788.00 | Price 3.94 | Shares 200
Sale 31 May 2012
Value US$26,656.00 | Price 3.92 | Shares 6,800
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2015-12-02 2015-11-30 B Purchase Gengos Andrew

President and CEO

Executive Director
12,011 -26.5%
75.86
US$3,289,322 		12,011 -26.5% 75.86 US$3,289,322
2015-02-20 2015-02-18 B Purchase Gringeri Anthony

Senior VP Strategic Resources

Officer
60,499 -39.6%
491.03
US$3,604,303 		60,499 -39.6% 491.03 US$3,604,303
2015-02-20 2015-02-18 B Purchase Gengos Andrew

President and CEO

Executive Director
36,261 -46.8%
230.13
US$585,853 		36,261 -46.8% 230.13 US$585,853
2015-02-20 2015-02-18 B Purchase FRACTOR DAVID

VP of Finance

Officer
16,667 +66.7%
0.60
US$10,000 		16,667 +66.7% 0.60 US$10,000
2014-08-22 2014-08-21 B Purchase Gringeri Anthony

Senior VP Strategic Resources

Officer
11,000 +44.0%
0.91
US$10,010 		11,000 +44.0% 0.91 US$10,010
2014-08-14 2014-08-14 B Purchase Gengos Andrew

President and CEO

Executive Director
10,000 +37.0%
0.90
US$8,994 		10,000 +37.0% 0.90 US$8,994
2013-12-20 2013-12-20 B Purchase Titus Gary Non-Executive Director
17,900 +17900.0%
0.78
US$13,962 		17,900 +17900.0% 0.78 US$13,962
2013-12-20 2013-12-20 B Purchase Titus Gary Non-Executive Director
100 +inf%
0.78
US$78 		100 +inf% 0.78 US$78
2013-12-18 2013-12-18 B Purchase Gengos Andrew

President and CEO

Executive Director
27,000 +inf%
0.72
US$19,362 		27,000 +inf% 0.72 US$19,362
2013-11-27 2013-11-26 PlS Planned sale COWELL RICHARD Non-Executive Director
8,301 -45.4%
3.86
US$32,030 		8,301 -45.4% 3.86 US$32,030
2013-11-27 2013-11-26 PlS Planned sale COWELL RICHARD Non-Executive Director
19,699 -66.3%
3.86
US$76,011 		19,699 -66.3% 3.86 US$76,011
2013-11-27 2013-11-25 PlS Planned sale COWELL RICHARD Non-Executive Director
30,301 -75.2%
3.50
US$106,096 		30,301 -75.2% 3.50 US$106,096
2013-11-27 2013-11-25 PlS Planned sale COWELL RICHARD Non-Executive Director
25,000 -71.4%
3.02
US$75,448 		25,000 -71.4% 3.02 US$75,448
2013-10-22 2013-10-21 S Sale Yu John S

Secretary

Executive Director
36,006 -100.0%
2.92
US$105,080 		36,006 -100.0% 2.92 US$105,080
2013-11-27 2013-10-18 PlS Planned sale Yu John S

Secretary

Executive Director
32,613 -100.0%
2.85
US$92,875 		32,613 -100.0% 2.85 US$92,875
2013-10-22 2013-10-18 PlS Planned sale Yu John S

Secretary

Executive Director
231,381 -100.0%
2.91
US$673,226 		231,381 -100.0% 2.91 US$673,226
2013-08-30 2013-08-29 S Sale Bender James G.

VP, Product Development & Mfg.

Officer
900 -90.0%
3.00
US$2,700 		900 -90.0% 3.00 US$2,700
2013-08-30 2013-08-28 S Sale Bender James G.

VP, Product Development & Mfg.

Officer
5,000 -83.3%
2.88
US$14,400 		5,000 -83.3% 2.88 US$14,400
2013-08-30 2013-08-28 S Sale Bender James G.

VP, Product Development & Mfg.

Officer
3,303 -35.5%
2.85
US$9,414 		3,303 -35.5% 2.85 US$9,414
2013-08-30 2013-08-28 S Sale Bender James G.

VP, Product Development & Mfg.

Officer
5,000 -35.0%
2.84
US$14,200 		5,000 -35.0% 2.84 US$14,200
2012-06-06 2012-06-01 S Sale Bender James G.

VP Product Development & Mfg.

Officer
600 -40.6%
3.61
US$2,166 		600 -40.6% 3.61 US$2,166
2012-06-06 2012-06-01 S Sale Bender James G.

VP Product Development & Mfg.

Officer
4,900 -76.8%
3.60
US$17,640 		4,900 -76.8% 3.60 US$17,640
2012-06-06 2012-06-01 S Sale Bender James G.

VP Product Development & Mfg.

Officer
1,500 -19.0%
3.59
US$5,385 		1,500 -19.0% 3.59 US$5,385
2012-05-31 2012-05-31 S Sale Bender James G.

VP, Product Development & Mfg.

Officer
200 -2.5%
3.94
US$788 		200 -2.5% 3.94 US$788
2012-05-31 2012-05-31 S Sale Bender James G.

VP, Product Development & Mfg.

Officer
6,800 -46.3%
3.92
US$26,656 		6,800 -46.3% 3.92 US$26,656
Explore more

More insider trading research around ImmunoCellular Therapeutics Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America